Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 387

1.

Dietary cosupplementation with vitamin E and coenzyme Q(10) inhibits atherosclerosis in apolipoprotein E gene knockout mice.

Thomas SR, Leichtweis SB, Pettersson K, Croft KD, Mori TA, Brown AJ, Stocker R.

Arterioscler Thromb Vasc Biol. 2001 Apr;21(4):585-93.

2.

Anti-atherogenic effect of coenzyme Q10 in apolipoprotein E gene knockout mice.

Witting PK, Pettersson K, Letters J, Stocker R.

Free Radic Biol Med. 2000 Aug;29(3-4):295-305.

PMID:
11035258
3.

Time-dependent changes to lipids and antioxidants in plasma and aortas of apolipoprotein E knockout mice.

Letters JM, Witting PK, Christison JK, Eriksson AW, Pettersson K, Stocker R.

J Lipid Res. 1999 Jun;40(6):1104-12.

4.

Coenzyme Q(10) supplementation inhibits aortic lipid oxidation but fails to attenuate intimal thickening in balloon-injured New Zealand white rabbits.

Choy KJ, Deng YM, Hou JY, Wu B, Lau A, Witting PK, Stocker R.

Free Radic Biol Med. 2003 Aug 1;35(3):300-9.

PMID:
12885592
5.

Palm tocotrienols protect ApoE +/- mice from diet-induced atheroma formation.

Black TM, Wang P, Maeda N, Coleman RA.

J Nutr. 2000 Oct;130(10):2420-6.

8.

Dietary antioxidants inhibit development of fatty streak lesions in the LDL receptor-deficient mouse.

Crawford RS, Kirk EA, Rosenfeld ME, LeBoeuf RC, Chait A.

Arterioscler Thromb Vasc Biol. 1998 Sep;18(9):1506-13.

11.

Dietary beta-carotene and alpha-tocopherol combination does not inhibit atherogenesis in an ApoE-deficient mouse model.

Shaish A, George J, Gilburd B, Keren P, Levkovitz H, Harats D.

Arterioscler Thromb Vasc Biol. 1999 Jun;19(6):1470-5.

12.

Plasma LDL oxidation leads to its aggregation in the atherosclerotic apolipoprotein E-deficient mice.

Maor I, Hayek T, Coleman R, Aviram M.

Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2995-3005.

14.

Cosupplementation with vitamin E and coenzyme Q10 reduces circulating markers of inflammation in baboons.

Wang XL, Rainwater DL, Mahaney MC, Stocker R.

Am J Clin Nutr. 2004 Sep;80(3):649-55.

15.

Chlamydia pneumoniae does not increase atherosclerosis in the aortic root of apolipoprotein E-deficient mice.

Aalto-Setälä K, Laitinen K, Erkkilä L, Leinonen M, Jauhiainen M, Ehnholm C, Tamminen M, Puolakkainen M, Penttilä I, Saikku P.

Arterioscler Thromb Vasc Biol. 2001 Apr;21(4):578-84.

16.

Proatherogenic and antiatherogenic effects of probucol and phytosterols in apolipoprotein E-deficient mice: possible mechanisms of action.

Moghadasian MH, McManus BM, Godin DV, Rodrigues B, Frohlich JJ.

Circulation. 1999 Apr 6;99(13):1733-9.

17.

Bone marrow transplantation in apolipoprotein E-deficient mice. Effect of ApoE gene dosage on serum lipid concentrations, (beta)VLDL catabolism, and atherosclerosis.

Van Eck M, Herijgers N, Yates J, Pearce NJ, Hoogerbrugge PM, Groot PH, Van Berkel TJ.

Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):3117-26.

18.

Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice.

Wassmann S, Czech T, van Eickels M, Fleming I, Böhm M, Nickenig G.

Circulation. 2004 Nov 9;110(19):3062-7. Epub 2004 Jul 26.

19.

Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice.

Davis HR Jr, Compton DS, Hoos L, Tetzloff G.

Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):2032-8.

20.

Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice.

Park TS, Panek RL, Mueller SB, Hanselman JC, Rosebury WS, Robertson AW, Kindt EK, Homan R, Karathanasis SK, Rekhter MD.

Circulation. 2004 Nov 30;110(22):3465-71. Epub 2004 Nov 15.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk